Back to HALO
ASSETMARK, INC HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$18.4M
Q3 2026
Peak value
$18.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $9M |
| Q4 2025 | $9.2M |
| Q1 2026 | $10.8M |
| Q2 2026 | $13.6M |
| Q3 2026 | $18.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $18.4M | 166.7K | — | — |
| Q2 2026 | $13.6M | 174.3K | — | — |
| Q1 2026 | $10.8M | 166.6K | — | — |
| Q4 2025 | $9.2M | 137.4K | — | — |
| Q3 2025 | $9M | 122.8K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M